{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T08:00:30Z","timestamp":1768896030019,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T00:00:00Z","timestamp":1568851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anales de Pediatr\u00eda"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.anpedi.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T05:35:50Z","timestamp":1572759350000},"page":"109.e1-109.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Recomendaciones de la Sociedad Espa\u00f1ola de Cardiolog\u00eda Pedi\u00e1trica y Cardiopat\u00edas Cong\u00e9nitas en relaci\u00f3n con el uso de medicamentos en el trastorno por d\u00e9ficit de atenci\u00f3n e hiperactividad en ni\u00f1os y adolescentes con cardiopat\u00edas conocidas y en la poblaci\u00f3n pedi\u00e1trica general, posicionamiento de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda"],"prefix":"10.1016","volume":"92","author":[{"given":"Javier","family":"P\u00e9rez-Lescure Picarzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Centeno Malfaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Collell Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Crespo Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Fern\u00e1ndez Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bego\u00f1a","family":"Manso Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henar","family":"Rojo Sombrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sabat\u00e9 Rot\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Sarquella-Brugada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anpedi.2019.09.002_bib0075","unstructured":"Centers for Disease Control and Prevention (CDC). Attention-deficit\/hyperactivity disorder (ADHD). [consultado 23 Ene 2019]. Disponible en: http:\/\/www.cdc.gov\/ncbddd\/adhd\/diagnosis.html"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0080","first-page":"80","article-title":"Se puede tratar el d\u00e9ficit de atenci\u00f3n con hiperactividad sin hacer un electrocardiograma","volume":"7","author":"Aparicio Rodrigo","year":"2011","journal-title":"Evid Pediatr."},{"key":"10.1016\/j.anpedi.2019.09.002_bib0085","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.107.189473","volume":"117","author":"Vetter","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00787-010-0140-6","article-title":"European guidelines on managing adverse effects of medication for ADHD","volume":"20","author":"Graham","year":"2011","journal-title":"Eur Child Adolesc Psychiatry."},{"key":"10.1016\/j.anpedi.2019.09.002_bib0095","series-title":"Canadian ADHD practice guidelines","year":"2018"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0100","unstructured":"Attention deficit hyperactivity disorder: Diagnosis and management NICE guideline March 2018. [consultado 24 Ene 2019]. Disponible en: nice.org.uk\/guidance\/ng87"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0105","author":"Taylor","year":"2009"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/jcpp.12036","article-title":"Practitioner review: Current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents","volume":"54","author":"Cortese","year":"2013","journal-title":"J Child Psychol Psychiatry."},{"key":"10.1016\/j.anpedi.2019.09.002_bib0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40263-017-0410-7","article-title":"Cardiovascular effects of stimulant and non-stimulant medication for children and adolescents with ADHD: A systematic review and meta-analysis of trials of methylphenidate, amphetamines and atomoxetine","volume":"31","author":"Hennissen","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0120","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics."},{"key":"10.1016\/j.anpedi.2019.09.002_bib0125","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jelectrocard.2017.02.012","article-title":"The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder","volume":"50","author":"Karpuz","year":"2017","journal-title":"J Electrocardiol"},{"key":"10.1016\/j.anpedi.2019.09.002_bib0130","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/HJH.0000000000001039","article-title":"2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents","volume":"34","author":"Lurbe","year":"2016","journal-title":"J Hypertens."},{"key":"10.1016\/j.anpedi.2019.09.002_bib0135","first-page":"171","article-title":"Hipertensi\u00f3n arterial en ni\u00f1os y adolescentes","volume":"1","author":"De la Cerda Ojeda","year":"2014","journal-title":"Protoc Diagn Ter Pediatr."},{"key":"10.1016\/j.anpedi.2019.09.002_bib0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/2042098616679636","article-title":"Attention-deficit hyperactivity disorder medication use: Factors involved in prescribing, safety aspects and outcomes","volume":"8","author":"Martinez-Raga","year":"2017","journal-title":"Ther Adv Drug Saf"}],"container-title":["Anales de Pediatr\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403319302747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1695403319302747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:49:34Z","timestamp":1761662974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1695403319302747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S1695403319302747"],"URL":"https:\/\/doi.org\/10.1016\/j.anpedi.2019.09.002","relation":{},"ISSN":["1695-4033"],"issn-type":[{"value":"1695-4033","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recomendaciones de la Sociedad Espa\u00f1ola de Cardiolog\u00eda Pedi\u00e1trica y Cardiopat\u00edas Cong\u00e9nitas en relaci\u00f3n con el uso de medicamentos en el trastorno por d\u00e9ficit de atenci\u00f3n e hiperactividad en ni\u00f1os y adolescentes con cardiopat\u00edas conocidas y en la poblaci\u00f3n pedi\u00e1trica general, posicionamiento de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda","name":"articletitle","label":"Article Title"},{"value":"Anales de Pediatr\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anpedi.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}